Studies advance methods to avert toxicity that can accompany immunotherapy – Medical Xpress
Medical Xpress |
Studies advance methods to avert toxicity that can accompany immunotherapy
Medical Xpress The first CAR T-cell product was recently approved by the U.S. Food and Drug Administration to treat certain leukemias. That product, like the one studied by the Fred Hutch team, reprograms patients' immune cells to kill blood cancer cells bearing a … |
